2010
DOI: 10.1523/jneurosci.4456-09.2010
|View full text |Cite
|
Sign up to set email alerts
|

Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation

Abstract: Amyloid ␤ (A␤)-containing plaques are surrounded by dystrophic neurites in the Alzheimer's disease (AD) brain, but whether and how plaques induce these neuritic abnormalities remain unknown. We tested the hypothesis that soluble oligomeric assemblies of A␤, which surround plaques, induce calcium-mediated secondary cascades that lead to dystrophic changes in local neurites. We show that soluble A␤ oligomers lead to activation of the calcium-dependent phosphatase calcineurin (CaN) (PP2B), which in turn activates… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

25
366
2
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 323 publications
(395 citation statements)
references
References 65 publications
25
366
2
1
Order By: Relevance
“…such as cyclosporine and FK-506 (tacrolimus), can revert these A␤-related pathological changes both in vitro and in vivo and ameliorate both the neuropathological features and the memory deficits of AD mouse models. 26,[51][52][53] In summary, our findings indicate a major role of gliosis in the pathophysiological features of both amyloid plaques and NFTs, suggesting that glial cells might be proactive players linking A␤ with downstream neurodegenerative events beyond their role in the initial steps of the amyloid cascade. The implications of these results for the development of imaging biomarkers and diseasemodifying drugs encourage further research.…”
Section: Diagnostic and Therapeutic Implicationsmentioning
confidence: 66%
See 1 more Smart Citation
“…such as cyclosporine and FK-506 (tacrolimus), can revert these A␤-related pathological changes both in vitro and in vivo and ameliorate both the neuropathological features and the memory deficits of AD mouse models. 26,[51][52][53] In summary, our findings indicate a major role of gliosis in the pathophysiological features of both amyloid plaques and NFTs, suggesting that glial cells might be proactive players linking A␤ with downstream neurodegenerative events beyond their role in the initial steps of the amyloid cascade. The implications of these results for the development of imaging biomarkers and diseasemodifying drugs encourage further research.…”
Section: Diagnostic and Therapeutic Implicationsmentioning
confidence: 66%
“…48,49 Fibrillar and particularly oligomeric A␤ can aberrantly activate this molecular signaling pathway in glial cells 48,50 and neurons, causing the morphological triad of dystrophic neurites, dendritic simplification, and loss of dendritic spines, subsequently leading to cognitive impairment. [51][52][53] More important, Food and Drug Administration-approved and available calcineurin inhibitors, Figure 7. A model of the progression of AD-related pathological features in the temporal neocortex based on the present results.…”
Section: Diagnostic and Therapeutic Implicationsmentioning
confidence: 99%
“…Plaque-associated dystrophic neurites are thought to be the result of the direct neurotoxic effect of Ab oligomers, 26 reactive oxygen species, 27 and the inflammatory milieu 28,29 that exist around dense-core plaques. There are many markers for plaque-associated dystrophic neurites, including amyloid precursor protein, phosphorylated neurofilament, ubiquitin, and phospho-tau.…”
Section: Discussionmentioning
confidence: 99%
“…The NFAT pathway is a master regulator of the immune response and is inhibited by ciclosporin, but can also display antiapoptotic actions in neurons [203,204]. However, Aβ-induced neuritic damage, in an in vitro model, mimics the increased intracellular calcium often seen in neurodegenerative disorders and is associated with upregulation of the calcineurin-NFAT pathway, inhibition of this pathway, both in vivo and in vitro, can reverse markers of neurodegeneration [205]. Indeed, in the brains of patients with AD, increased nuclear NFAT is a common finding-and cognitive decline in this disease is associated with selective changes calcineurin/NFAT signaling.…”
Section: Cbd Receptor Targets In Neurodegenerationmentioning
confidence: 99%